Coronary heart disease mortality – CHD deaths · adults with or without existing CVD
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
CHD events · adults with or without existing CVD
High may leads to lower coronary heart disease events – CHD events compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
Stroke · adults with or without existing CVD
High showed no clear difference in stroke compared with low long‐chain omega‐3 fats (moderate certainty).
1 finding from 1 review
Arrhythmias · adults with or without existing CVD
High showed no clear difference in arrhythmias compared with low long‐chain omega‐3 fats (low certainty).
1 finding from 1 review
Harms: bleeding · adults with or without existing CVD
It is very uncertain whether high changes harms: bleeding compared with low long‐chain omega‐3 fats (very low certainty).
1 finding from 1 review
Harms: pulmonary embolus or DVT · adults with or without existing CVD
It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low long‐chain omega‐3 fats (very low certainty).
1 finding from 1 review
Intervention not reported
Cognition: BSID II score at < 24 months · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The intervention showed no clear difference in cognition: BSID II score at < 24 months (low certainty).
1 finding from 1 review
Intervention not reported
Cognition: BSID III score at < 24 months · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The intervention showed no clear difference in cognition: BSID III score at < 24 months (low certainty).
1 finding from 1 review
Intervention not reported
IQ: WASI at 7 years · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The intervention showed no clear difference in IQ: WASI at 7 years (low certainty).
1 finding from 1 review
Intervention not reported
IQ: WISC‐IV at 12 years · children of women randomised to omega‐3 or no omega‐3 during pregnancy
It is very uncertain whether the intervention changes IQ: WISC‐IV at 12 years (very low certainty).
1 finding from 1 review
Intervention not reported
Behaviour: BSID III adaptive behaviour score at 12‐18 months · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The intervention showed no clear difference in behaviour: BSID III adaptive behaviour score at 12‐18 months (low certainty).
1 finding from 1 review
Intervention not reported
Behaviour: SDQ Total Difficulties at 7 years · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The intervention may leads to higher behaviour: SDQ Total Difficulties at 7 years (low certainty).
1 finding from 1 review
Intervention not reported
BMI at 19 years · children of women randomised to omega‐3 or no omega‐3 during pregnancy
It is very uncertain whether the intervention changes BMI at 19 years (very low certainty).
1 finding from 1 review
Intervention not reported
Diabetes · children of women randomised to omega‐3 or no omega‐3 during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptomology (continuous) HDRS where possible; higher scores indicate greater symptomology · adults with Major Depressive Disorder
1 finding from 1 review
Adverse events Study reports · adults with Major Depressive Disorder
It is very uncertain whether n3PUFAs changes adverse eventsStudy reports compared with placebo (very low certainty).
1 finding from 1 review
Depressive symptomology (dichotomous ‐ remission) Depressive symptomology rating scale as used by authors · adults with Major Depressive Disorder
n3PUFAs showed no clear difference in depressive symptomology (dichotomous ‐ remission)Depressive… compared with placebo (low certainty).
1 finding from 1 review
Depressive symptomology (dichotomous ‐ response) Depressive symptomology rating scale as used by authors · adults with Major Depressive Disorder
n3PUFAs showed no clear difference in depressive symptomology (dichotomous ‐ response)Depressive… compared with placebo (low certainty).
1 finding from 1 review
Quality of lifeValidated quality of life scales as used by authors, CGI (7‐point scale) where possible, higher scores indicate poorer quality of life · adults with Major Depressive Disorder
1 finding from 1 review
Trial non‐completionStudy reports · adults with Major Depressive Disorder
It is very uncertain whether n3PUFAs changes trial non‐completionStudy reports compared with placebo (very low certainty).
1 finding from 1 review